Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
HRS 2026: AF Burden, Outcomes, and Anticoagulation in Device-Detected AF
Author(s): Ulrich Schotten Added: 1 week ago
HRS Congress 2026 — Prof Ulrich Schotten (Maastricht University, Maastricht, NL) joins us to discuss new findings from the NOAH-AFNET 6 trial examining the distribution of atrial fibrillation burden, its relationship to clinical outcomes, and the effectiveness and safety of anticoagulation based on device reports.NOAH-AFNET 6 (Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial… View more

Electrophysiology & Arrhythmia
AF Symposium 25: LAAC Vs Oral Anticoagulation After Catheter Ablation
Author(s): Walid Saliba Added: 1 year ago
AF Symposium 25 - Left atrial appendage (LAA) closure using the WATCHMAN FLX device (Boston Scientific) showed lower risk of bleeding and non-inferiority in efficacy endpoints to oral anticoagulation in patients who have received or are planning to receive AF ablation.Dr Walid Saliba (Cleveland Clinic, OH, US) joins us onsite at AF Symposium 25 to discuss the findings from the concomitant and… View more

Anticoagulation

Electrophysiology & Arrhythmia
AHA 25: The OCEAN Trial
Author(s): Atul Verma Added: 6 months ago
AHA Scientific Sessions 2025 - Dr Atul Verma (McGill University Health Centre, Montreal, CA) joins us to share outcomes from OCEAN (NCT02168829). The prospective, open-label, randomised trial aimed to investigate ongoing oral anticoagulation with rivaroxaban 15 mg daily compared to antiplatelet therapy in patients with clinical stroke risk factors at least one year post-successful catheter… View more

Anticoagulation

Electrophysiology & Arrhythmia
Revolutionising Thrombosis Treatment in ACS, SSP and AF: Bridging the Gaps With Next Generation Anticoagulation Strategies
Author(s): Davide Capodanno , Sneha Shah Jain Added: 8 months ago
Presented at the European Society of Cardiology (ESC) Congress 2025, Prof Carolyn Lam (Singapore, UK), Prof Davide Capodanno (Catania, IT), Dr Sneha Shah Jain (Stanford, US) and Prof Jeffrey Weitz (Hamilton, CA) examine the prevalence and challenges of stroke prevention in atrial fibrillation (AF) and after acute coronary syndrome (ACS). The faculty review current treatment guidelines, explore… View more

Anticoagulation

Electrophysiology & Arrhythmia
EHRA 24: A Substudy of NOAH-AFNET 6
Author(s): Julius Nikorowitsch Added: 2 years ago
EHRA 24 - We are joined onsite by Dr Julius Nikorowitsch (University Heart and Vascular Centre Hamburg (UHZ), DE) to outline the impact of age, sex, cardiovascular comorbidities, and kidney function on outcomes with oral anticoagulation therapy in patients with device-detected atrial fibrillation in a substudy of the NOAH-AFNET 6 trial (NCT02618577).The substudy consisted of 2534 patients from… View more

Electrophysiology & Arrhythmia
Deborah Siegal
Job title: Hematologist
Dr Deborah Siegal MD MSc FRCPC is a hematologist at The Ottawa Hospital, Associate Professor of Medicine at the University of Ottawa and Scientist at the Ottawa Hospital Research Institute. She holds a Tier 2 Canada Research Chair in Anticoagulant Treatment of Cardiovascular Disease. She received MSc degrees in Pharmacology and Health Research Methodology.Her primary research areas include (i)… View more
Inside the Cath Lab: Interventional AF Leaders on Stroke Prevention
Author(s): Karim Al-Azizi , Devi Nair , Added: 1 week ago
In this expert discussion, DrKarim Al-Azizi(Baylor Scott & White The Heart Hospital, US), Editor-in-Chief of the Transcatheter Academy, is joined by steering committee members DrDevi Nair(Chief VP of Research, Arkansas Heart Hospital, US) and DrMegan Coylewright(Essentia Health, US) to unpack the landmark CHAMPION-AF trial (NCT05964200) and its implications for stroke prevention in atrial… View more

Intervention

Electrophysiology & Arrhythmia
Device-detected AF: How Much is Too Much?
Author(s): Jude Scott Added: 1 week ago

Imaging & Diagnostics

Prevention & Chronic Conditions
ACC.26 Late-breaker Discussion: The CHAMPION-AF Trial
Author(s): Saibal Kar , Harriette Van Spall Added: 1 month ago
ACC.26 – Late-breaker host Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Saibal Kar, MD (Los Robles Regional Medical Center, US) to discuss CHAMPION‑AF (NCT04394546), a global randomized trial comparing the WATCHMAN FLX left atrial appendage closure device with non–vitamin K oral anticoagulants in patients with non‑valvular atrial fibrillation at elevated stroke risk… View more

Intervention

Anticoagulation
One-Stop PVI and LAA Closure: A Concomitant AF Ablation Case
Author(s): Added: 1 month ago
Dr Amr Nawar (Sultan Qaboos University Hospital, Muscat, OM) walks through a concomitant pulmonary vein isolation (PVI) and left atrial appendage (LAA) closure procedure in a single 90-minute session — treating the arrhythmia and addressing embolic risk simultaneously.The case centres on a 70-year-old male with atrial fibrillation and a history of two transient ischaemic attacks. Dr Nawar details… View more

Electrophysiology & Arrhythmia